The present studies were aimed at investigating the possible roles of dopamine (DA) and iron in production of hydroxyl radicals ( · OH) in rat striatum after Mn 21 intoxication. For this purpose, DA depletions were assessed concomitant with in vivo 2,3-and 2,5-dihydroxybenzoic acid (DHBA) formation from the reaction of salicylate with · OH, of which 2,3-DHBA is a nonenzymatic adduct. Following intrastriatal Mn 21 injection, marked 2,3-DHBA increases were observed in a time-and dose-dependent fashion reaching maximum levels at 6-18 h and a plateau beyond 0.4 mmol 
INTRODUCTION
Chronic inhalation of manganese (Mn) dust or vapor in humans and monkeys causes parkinsonism and dystonia (3, 4, 17) and produces selective neuropathology in the basal ganglia with lesions being localized both pre-and postsynaptically to the dopaminergic (DA) nigrostriatal pathway (8, 19-21, 62, 63) . In addition, Mn 21 injection into the basal ganglia of rats (8, 40, 46, 47, 54) provides a model of chronic systemic Mn exposure in humans. For more than a decade, it has been hypothesized from in vitro studies that Mn neurotoxicity is mediated by free radicals via enhanced nonenzymatic autoxidation of catecholamines (1, 26, 27, 30, 42) or production of 6-hydroxydopamine (6-OHDA) (12, 13, 23) . Both processes would lead to production of toxic (semi)quinones and enhanced levels of H 2 O 2 and superoxide anion radicals (O 2 ·2 ) as well as hydroxyl radicals ( · OH). This concept is in agreement with attenuation of Mn 21 -induced DA depletion by vitamin E treatment (48) . On the other hand, it has been reported that lipid peroxidation is inhibited by Mn 21 both in vitro (11, 60) and in postmortem brain tissues of Mn 21 -exposed rats (16, 53) . In addition, in vitro studies have shown that Mn produces irreversible DA depletion by oxidation to quinones without the formation of reactive oxygen species (1, 51) .
Although production of (semi)quinones or free oxygen radicals after Mn has not been reported in vivo, it seems likely that DA plays a role in Mn neurotoxicity. For instance, pretreatment with the DA synthesis blockers a-methyltyrosine and lisuride attenuates the neurotoxicity of Mn 21 (47) , whereas the monoamine oxidase inhibitor pargyline and L-DOPA (1carbidopa) potentiate its toxicity (46) .
Besides DA, brain iron could mediate neurotoxic effects of Mn 21 . The selective accumulation of Mn 21 in the basal ganglia (19, 41, 45) and anterograde axonal transport of Mn 21 in nigrostriatal and striatonigral neurons (55) may be dependent on iron transport and storage pathways (2, 6, 32, 33, 44) . In vitro studies have shown that Mn binds to the iron transport protein transferrin and its receptor on catecholamine-containing neuroblastoma cells and that Mn-like Fe-is internalized followed by storage into ferritin (59) . Therefore, Mn 21 may (in)directly liberate endogenous iron by disturbing iron homeostasis, particularly in mitochondria. In these organelles, Mn 21 induces decreased gluthatione (GSH) contents and GSH enzyme activities (38) , thereby compromising a major cellular defense mechanism against oxyradicals. In addition, Mn 21 has been reported to impair ATP production, decrease respiratory cytochrome contents, inhibit oxidative phosphorylation, and increase lactate production (9, 39, 25) .
The aim of the present studies was twofold. First, time-and dose-dependent · OH formation by Mn 21 was assessed in relation to DA and serotonin (5-HT) depletions in order to examine whether · OH generation is cause or consequence of brain damage. Like DA, 5-HT levels are depleted by Mn within the choosen time span of 24 h (54), which may significantly contribute to the formation of both quinones and free oxyradicals (43) . In this study we used salicylate (SA) as an · OH-trapping agent, which forms the stable adducts 2,3-and 2,5-dihydroxybenzoates (DHBA) (35, 56 and references therein), and microinjections of Mn 21 into rat striatum as described previously (55) . Since it has been reported that 2,5-DHBA can also be formed via P450 enzymes, which is not the case for 2,3-DHBA, the latter is a more reliable index for · OH formation (35) . Second, the roles of DA and iron in generating Mn 21 -induced · OH formation were investigated by analyzing 2,3-DHBA levels in striata of reserpine-pretreated (DA-depleted) or deferoxamine-treated (iron-chelated) rats, as well as by assessing different endogenous iron pools in Mn 21 -injected striata.
MATERIAL AND METHODS

Animals
Wistar-derived male rats (WAG, Harlan, Zeist, The Netherlands) were kept on a 12/12-h light/dark cycle and housed in a room with a humidity of 50-70% and a temperature of 24°C with free access to water and chow food. Animal experimentation protocols were approved by the Ethical Committee for Laboratory Animals Experiments, TNO/Regio West (Woudenberg, The Netherlands, Reg. No. 56-3A).
Materials
MnCl 2 (.96% pure), FeCl 2 · 4H 2 O (.99% pure), MgCl 2 · 6H 2 O, and dopamine (3-hydroxytyramine · HCl) were obtained from Merck (Darmstadt, Germany). Solutions of metals were made as described previously (55) . All other compounds were purchased from Sigma (Brunschwig Chemie, Amsterdam, The Netherlands) and stored according to the description of the manufacturer.
Experimental Groups
Chloralhydrate-anesthetized (400 mg/kg ip) rats (190-230 g) received unilateral injections of MnCl 2 , FeCl 2 , or MgCl 2 in 1 µl of Milli-Q water (Millipore, Molsheim, France) into striatum using stereotaxic procedures as described previously (55) .
DHBA formation by Mn: Time course and dosedependency. Two, six, or eighteen hours after intrastriatal injection of 0.4 µmol Mn 21 , or 6 h after injection of 0.4 µmol Mg 21 , rats (n 5 6-7 per group) were decapitated to dissect striatal tissues from the brain. Likewise, rats (n 5 6-7 per dose) were injected with 0.13 or 1.20 µmol Mn 21 6 h before collection of their striata. In addition, 2 h prior to sacrifice, rats were loaded with 300 mg/kg SA (ip), whereas others (6-8 striata per group) did not receive SA to serve as negative controls.
DHBA formation by Mn after dopamine depletion. Eight rats were depleted of dopamine by 24-h pretreatment with reserpine (10; 2.5 mg/kg ip). These rats received a unilateral injection of 0.4 µmol Mn 21 into striatum and were decapitated 6 h later. In addition, SA (300 mg/kg ip) was given 2 h before sacrifice.
Effect of Mn on total and low molecular weight (LMW) iron levels. Six hours after bilateral injection of 0.4 µmol Mn 21 , Mg 21 , or Fe 21 into striatum, rats (n 5 4-8 per treatment) were decapitated and their striata were dissected for immediate assay of total and LMW iron contents.
Effect of deferoxamine on Mn neurotoxicity. Ten rats received an injection (1 µl total) of 0.4 µmol Mn 21 plus 0.2 or 2.0 nmol deferoxamine mesylate (Desferal; DFX) into the left striatum and 0.4 µmol NaCl plus DFX into the right striatum. Six control rats received similar bilateral injections without DFX. All rats were loaded with SA (300 mg/kg ip) and sacrificed respectively 4 and 6 h after stereotaxic injection.
Collection of Samples
Collection and handling of samples for analysis of DA, 5-HT, SA, and related metabolites was done as described previously (56) . Briefly, dissected striatal tissues (20-40 mg wet wt) were immediately frozen on dry ice and stored at 270°C. At the day of analysis, striata were sonicated in ice-cold 200 µl perchloric acid containing Na 2 S 2 O 5 , centrifuged, diluted with mobilephase buffer, and kept on ice before injection into the HPLC system.
For analysis of iron, freshly dissected striatal tissues were immediately weighed in preweighed potter tubes, homogenized in 100 mM Tris/HCl buffer (pH 7.4, 20% w/v), and subsequently DFX (2 mM final concentration) was added as described previously for heart tissue (61). Depending on expected concentrations, striatal tissues of 1 or 2 rats were pooled before homogenizing.
Analysis of 6-Hydroxydopamine, Dopamine, Serotonin, Salicylate, and Related Metabolites
Levels of SA, 2,3-and 2,5-DHBA, as well as 6-OHDA, DA, 5-HT, and their metabolites DOPAC (3,4-dihydroxyphenylacetic acid), HVA (4-hydroxy-3-methoxyphenylacetic acid), and 5-HIAA (5-hydroxyindole-3-acetic acid) were determined in striatal tissues according to a previously described HPLC procedure with UV absor-bance and electrochemical detection (56) . Since 6-OHDA standards had a retention time between 2,3-and 2,5-DHBA standards, 6-OHDA measurements were conducted in samples without SA with a detection limit of about 50 fmol. Briefly, a Spherisorb ODS2 cartridge analytical column (100 3 4.6 mm, 3 µm) with a ODS1 precolumn (30 3 4.6 mm, 5 µm) (Phase Separation, Ltd., Deeside, UK) was used to separate the compounds of interest at a flow rate of 0.8 ml/min. The mobilephase buffer consisted of 0.1 M sodium acetate, 6.0% methanol, 19.5 mg/liter n-octyl sodium sulfate (Merck, Darmstadt, Germany), and 10-15 mg/liter Na 2 ethylenediaminetetraacetate (EDTA) dissolved in Milli-Q water and adjusted to pH 4.1 with glacial acetic acid. Stock solutions of standards (,1 mM) dissolved in 50 mM HCl containing 0.20 g/liter Na 2 S 2 O 5 and 0.050 g/liter Na 2 EDTA were stable for at least 2 months if kept stored in the dark at 4°C.
Analyses of Total and Low Molecular Weight Iron Pools
After centrifuging the striatal homogenate at 10,000g for 15 min, the supernatant was removed for LMW iron measurements in presence of the hexadentate iron chelator DFX (61), which forms a strong complex with iron: ferrioxamine (FX). LMW iron assays were conducted under physiological or reducing conditions by adding ascorbic acid (20 mg/ml in solid state). Ascorbic acid was used to reduce iron from its ferric to its ferrous state, thereby liberating iron from Fe 31 complexes, resulting in total LMW iron measurements. Briefly, samples were incubated for 60 min at 37°C and prepurified by passing them through a 50-mg Extract-Clean C18 column (Alltech) on which DFX and FX are retained. After washing with 0.3 ml water and elution with 0.2 ml 90% methanol/10% water, the eluate was injected into the HPLC system, which was equipped with an ODS2 analytical column (as mentioned above) and two variable wavelength detectors to allow simultaneous detection of FX at 430 nm and DFX at 229 nm (Waters 484). The mobile phase consisted of 88% 20 mM Na 2 HPO 4 /NaH 2 PO 4 , 2 mM NaEDTA, 0.2 M triethylammonium chloride (pH 6.6) and 12% acetonitrile. Recovery of DFX and FX was respectively .80% and almost 100%. The detection limit for FX was 0.25 nmol. Iron levels were based on FX/DFX ratios from FeSO 4 standards incubated and extracted as the samples. Mn 21 (100-to 800-fold excess) did not affect chelation of iron by DFX in this procedure.
Total iron in the resuspended pellet (20% w/v in Tris/HCl) was determined using the iron(II) chelator Ferrozine essentially according to Riederer et al. (50) . Briefly, samples were added with Ferrozine (4.2 mM ), ascorbic acid (20 mg/ml) to reduce iron, and pepsine (0.1%) at a final pH of 2.5 using HCl. Subsequently, samples were incubated at 37°C for 20 min, and absorbances were read at 560 nm. Blank and standard iron samples were treated in a similar manner. Mn 21 did not affect chelation of iron by Ferrozine.
Statistics
Changes of the differences between ipsi-and contralateral tissues over time or with increasing dose were statistically evaluated using ANOVA (BMDP Statistical Software program SOLO, Los Angeles) followed by Newman-Keuls multiple comparisons test. In addition, the effect of time or dose in contra-or ipsilateral striata were also tested. Differences between values of ipsiand contralateral tissues at the separate time points or doses were evaluated using Student's t test. 21 over time (P , 0.001), reaching maximum levels at 6 h for both 2,3-DHBA (4.1-fold increase) and 2,5-DHBA (6.9-fold increase) and no significant increase between 0 and 2 h of 2,3-DHBA/SA ratios (Fig. 1) .
RESULTS
Time-Dependent
DA levels ( Fig. 1) were significantly decreased by Mn 21 at 2 h (253%) and declined further thereafter until at least 18 h (265%) compared to contralateral tissues (P , 0.001). Serotonin levels ( Fig. 1) were significantly decreased (249%) by Mn 21 at 2 h and declined further thereafter reaching the lowest levels at 18 h (273% of contralateral striatum).
DOPAC (1.7-fold) and HVA (1.5-to 1.7-fold) levels were significantly increased by Mn 21 at 2 and 6 h and were significantly decreased at 18 h (240% and 265% of contralateral striatum, respectively). The resulting DA turnover expressed as DOPAC/DA and HVA/DA ratios was significantly elevated at 2 h (3.3-and 2.8-fold, respectively) and declined thereafter until a still-significant increase of DOPAC/DA ratios (1.6-fold of contralateral) and normal HVA/DA ratios at 18 h (Fig. 2) . 5-HIAA levels were significantly decreased (239%) by Mn 21 at 2 h and declined further thereafter until 269% of contralateral tissue at 18 h. The resulting 5-HIAA/5-HT ratios were slightly, but significantly, elevated by Mn 21 (P , 0.001), but did not change between 2, 6, and 18 h (Fig. 2) .
In noninjected (contralateral) striatum, the means 6 SEM of 2,3-and 2,5-DHBA/SA values and DA, 5-HT, DOPAC, HVA, and 5-HIAA levels were respectively 0.30 6 0.033 and 2.03 6 0.11 mmol/mol SA and 68.9 6 1.43, 3.15 6 0.08, 5.16 6 0.16, 4.71 6 0.16, and 4.38 6 0.08 pmol/mg, except at 2 h where levels of DA, DOPAC, and HVA were significantly elevated (P , 0.001). The latter effect is most likely due to chloralhydrate anesthesia (Westerink, 1985) . DHBA increases reached plateau levels by 0.4 µmol Mn 21 (respectively 4.2-and 6.9-fold).
Dose-Dependent Effects of Mn 21 at 6 h
DA levels (Fig. 3) were significantly reduced by 0.13 µmol Mn 21 (215%), and declined dose-dependently to 287% by 1.2 µmol. Control injections with Mg 21 increased DA levels slightly, but significantly (114%; P , 0.05). Serotonin levels (Fig. 3) were significantly reduced by 0.13 µmol Mn 21 (255%) and declined dosedependently until 276% of contralateral tissues (P , 0.001). Following Mg 21 injections, 5-HT levels were slightly, but significantly, decreased (214%; P , 0.05).
DOPAC and HVA levels were significantly increased by 0.13 µmol Mn 21 (respectively 1.9-and 2.4-fold) and declined dose-dependently reaching levels of 251% and 232% at 1.2 µmol, respectively. Mg 21 injections increased DOPAC (161%) and HVA (188%) levels significantly (P , 0.001). The resulting DOPAC/DA and HVA/DA ratios were significantly increased in a dosedependent manner (P , 0.01), reaching 4.9-and 7.8-fold elevations by 1.2 µmol Mn 21 , respectively (Fig. 4) . 5-HIAA levels were significantly reduced by 0.13 µmol Mn 21 (241%) and declined dose-dependently until 276% (P , 0.001). The resulting 5-HIAA/5-HT ratios were not dose-dependently changed by Mn 21 (P 5 0.32) (Fig. 4) .
Detection of 6-OHDA after Mn 21
In Mn 21 -injected striata of rats not loaded with SA, no peaks at the position of 6-OHDA standards were observed (data not shown).
Effect of Reserpine Pretreatment on Mn Neurotoxicity
The striatal DA and 5-HT contents of rats pretreated with reserpine were depleted by 89 and 56%, respectively. In reserpine-treated rats, Mn 21 injections did not significantly decrease DA levels any further compared to contralateral tissues (P 5 0.39 by Student's t test, Fig. 5 ) in contrast to a significant further decrease of 5-HT levels until 276%. 2,3-DHBA/SA ratios were significantly higher (P , 0.001) in both noninjected (2.1-fold) and Mn 21 -injected striata (1.7-fold) of reserpine-treated rats compared to striata of control rats (Fig. 5) . A similar significant effect for 2,5-DHBA/SA was observed in this respect (respectively 1.9-and 1.9-fold). The Mn 21 -induced 2,3-DHBA formation (expressed as ipsi-/contralateral ratios of DHBA/SA) in reserpine-treated rats (2.8-fold) was not significantly different from that in control rats (4.2-fold). The same was found for 2,5-DHBA formation in this respect (respectively 6.5-versus 6.9-fold).
Effect of Mn 21 on Total and LMW Iron in Striatum
Six hours after intrastriatal injection, Mn 21 produced no significant changes in striatal LMW or total iron pools compared to Mg 21 -or not-injected tissues (Table 1) . Furthermore, striatal LMW iron levels of Mn 21 -or Mg 21 -injected rats were similar when measured under reducing or nonreducing conditions. In contrast, 6 h after intrastriatal Fe 21 -injection, both LMW and total iron pools in striatum were markedly increased. In addition, in these striata, under reducing conditions, about 15-fold more iron was chelated by DFX in the LMW pool than in physiological medium. This difference can be due to a fine ferric hydroxide precipitation.
Effects of Deferoxamine on Mn Neurotoxicity
Co-injections of Mn 21 with 0.2 or 2.0 nmol DFX into striatum did not significantly alter 2,3- (Table 2) or 2,5-DHBA/SA increases or the extent of DA depletions (Table 2 ) compared to Mn 21 injections without DFX. There were no significant effects of DFX in contralateral tissues. Differences between ipsi-and contralateral levels of 2,3-DHBA/SA, 2,5-DHBA/SA, and DA were highly significant in all tested groups (P , 0.001). The means 6 SEM of 2,3-and 2,5-DHBA/SA (mmol/mol SA) and DA levels (pmol/mg) after NaCl injection were respectively 0.40 6 0.03, 2.1 6 0.24, and 72.7 6 3.4.
DISCUSSION
The present studies using SA as a · OH-trapping agent demonstrate time-and dose-dependent · OH formation by Mn 21 in the living brain. Furthermore, Mn does not catalyze the Haber-Weiss reaction in vivo. Additional experiments indicate that Mn 21 -induced · OH are not generated as a result of DA oxidation nor by an increase in (free) chelatable endogenous iron.
Pronounced increases of 2,3-DHBA/SA ratios (up to 4-fold) in Mn 21 -injected striatum compared to controls (Figs. 1 and 3) suggest that Mn 21 induces · OH formation. In addition, our results indicate that · OH are not triggered by Mn itself, because maximum levels are   FIG. 4 . Dose-dependent changes of dopamine and serotonin turnover 6 h after a unilateral control (Mg 21 ) or Mn 21 injection (dose as indicated) into striatum of salicylate-loaded rats (300 mg/kg ip; 2 h). Data represent [ipsi-/contralateral] ratios of [metabolite/neurotransmitter] ratios of 6-7 rats. DA turnover changed dose-dependently (ANOVA; P , 0.005 for DOPAC/DA and P , 0.01 for HVA/DA), whereas the 5-HT turnover did not. For more details see legend to Fig. 3 .
FIG. 5.
Effect of pretreatment with reserpine (2.5 mg/kg ip; 24 h) on 2,3-DHBA (mmol/mol SA; top) and dopamine levels (pmol/mg; (bottom) in striatum 6 h after unilateral injection of 0.4 µmol Mn 21 into striatum of SA-loaded rats (300 mg/kg ip; 2 h). Significant differences between Mn 21 -injected (hatched bars) and noninjected contralateral striata (C, white bars) are indicated by asterisks (Student's t test; P , 0.001). Both basal 2,3-DHBA/SA (noninjected side) and increased 2,3-DHBA/SA by Mn 21 were significantly higher in reserpine-treated rats than in control rats (#, P , 0.001 by Student's t test). However, the increases of 2,3-DHBA/SA (expressed as [ipsi-/contralateral] ratios) by Mn 21 between reserpine-treated (2.8-fold) and control rats (4.2-fold) were not significantly different (P 5 0.16, Student's t test). DA levels (bottom) were significantly depleted by reserpine (not indicated, Student's t test; P , 0.001).
only reached after 6-18 h. The time course of 2,3-DHBA formation after Mn 21 is very different from that after equimolar injections of Fe 21 into striatum, where highest increases of 2,3-DHBA (10-fold) were observed after 30 min (57) . Therefore, the present findings suggest that Mn 21 cannot catalyze the Haber-Weiss reaction in vivo, which is supported by in vitro studies (1 and references therein, 30).
DA and 5-HT depletions in striatum by Mn 21 are time-and dose-dependent and are not directly related to · OH formation (Figs. 1 and 3) . In contrast to DA and 5-HT levels, 2,3-DHBA formation (ipsi-/contralateral ratio of 2,3-DHBA/SA) was not significantly changed at 2 h and also did not change when the Mn 21 -dose was increased from 0.4 to 1.2 µmol Mn 21 . This independent action of Mn 21 on these two processes was in line with our subsequent studies with reserpine-treated rats. Mn 21 -induced · OH formation was not attenuated in the DA-depleted striatum (Fig. 5) . Furthermore, in the reserpine-treated rat with 90% depletion of striatal DA, Mn 21 did not cause additional DA reduction. Thus, Mn 21 -induced · OH formation is independent of depletion cq. oxidation of DA by Mn 21 . Indeed, in vitro studies on the mechanism of Mn 2/31 -induced oxidation of DA revealed that DA is rapidly and irreversibly oxidized by Mn 31 to its cyclized orthoquinone, resulting in decreased levels of DA, but does not generate reactive oxygen species since oxygen is neither consumed nor required in this reaction (1, 51) . In conclusion, a similar process seems to occur in vivo. The twofold elevation of basal · OH production in striatum after reserpine treatment (Fig. 5 ) is in line with another study in which reserpine increased levels of oxidized GSH in striatum, an indication of oxidative stress (58) .
It has been suggested that toxic quinones as a consequence of DA oxidation (by Mn) may compomise cellular defense mechanisms against oxyradicals (51) , for instance by GSH depletion (26, 27, 38, 43) . Our results obtained at 6 h after Mn 21 in reserpine-treated rats do not support this hypothesis. However, an increase of oxidative stress by quinones, and therefore a role of DA in Mn neurotoxicity, cannot be ruled out at later time points.
The increased production of another reactive oxygen species, H 2 O 2 , due to enhanced enzymatic turnover of DA (DOPAC/DA and HVA/DA ratios), which has been hypothetically linked with oxidative stress (14, 58), does not parallel 2,3-DHBA formation after Mn 21 both in time (Fig. 2) and with increasing dose (Fig. 4 ). This indicates that not H 2 O 2 production from enzymatic DA oxidation, but other factors determine · OH generation. In addition, the serotonin turnover was only slightly affected by Mn 21 , indicating a different (initial) response of both types of neurons to Mn 21 exposure. 21 -injected striata indicated that our assay procedures worked. Thus, ''free'' or LMW iron does not participate in Mn 21 -induced · OH formation unless (very) local increases play a role. Therefore intrastriatal co-injections of Mn 21 with the iron chelator DFX were conducted using doses known to retard 6-OHDA neurodegeneration (7) and sufficient to chelate the measured LMW iron pool completely. However, different intrastriatal DFX injections could not attenuate Mn 21 -induced 2,3-DHBA formation (Table 2) , which is consistent with our data on LMW iron. An important additional fact which supports the latter conclusion is that iron chelation by DFX in large excess of Mn 21 was not affected in vitro.
The question then arises, are there other mechanisms which may be responsible for Mn 21 -induced · OH? We propose two other mechanisms. First, Mn 21 accumulates preferentially in mitochondria via the Ca 21 uniporter, thereby inhibiting its own and Ca 21 effluxes (24) and impairing several mitochondrial respiratory functions and GSH metabolism (9, 25, 38, 39) . Under such conditions, disturbances of cytochrome heme metabolism (38, 49) and/or heme-associated electron transfers by Mn 21 may lead to oxoheme oxidants in the presence of H 2 O 2 or the postulated heme-associated ferryl radicals (18, 28, 29, 48) , which may cause SA hydroxylation in our studies (48) . DFX can probably not chelate iron from heme proteins, and this may explain the lack of an effect of DFX on Mn 21 -induced · OH.
Recently, protection has been shown by NO-synthase inhibitors after brain injury by some mitochondrial toxins (52) . Since Mn 21 also acts like a mitochondrial toxin that may raise NO, · OH may be derived from the decomposition of peroxynitrite, which is a reaction product of NO and O 2 ·2 (5, 15, 37, 34). In conclusion, selective regional accumulation of Mn 21 in the basal ganglia and its preferential sequestration in mitochondria may lead to local oxyradical formation and mitochondrial dysfunctions, which eventually result in selective cell death. The present studies have shown that DA and chelatable iron do not contribute to Mn 21 -induced · OH. Therefore, other mechanisms explaining oxidant stress after Mn 21 intoxication such as site-specific · OH formation through mitochondrial heme-iron moieties or peroxynitrite formation should be studied. An additional role of DA quinones in producing oxidative stress remains to be elucidated.
